Literature DB >> 32141424

Considerable variability in antibiotic use among US children's hospitals in 2017-2018.

Leigh M Howard1, Carlos G Grijalva2, Hannah G Griffith2, Keerti Dantuluri1, Cary Thurm3, Derek J Williams1, Ritu Banerjee1.   

Abstract

OBJECTIVE: To characterize the prevalence of and seasonal and regional variation in inpatient antibiotic use among hospitalized US children in 2017-2018.
DESIGN: We conducted a cross-sectional examination of hospitalized children. The assessments were conducted on a single day in spring (May 3, 2017), summer (August 2, 2017), fall (October 25, 2017), and winter (January 31, 2018). The main outcome of interest was receipt of an antibiotic on the study day.
SETTING: The study included 51 freestanding US children's hospitals that participate in the Pediatric Health Information System (PHIS). PATIENTS: This study included all patients <18 years old who were admitted to a participating PHIS hospital, excluding patients who were admitted solely for research purposes.
RESULTS: Of 52,769 total hospitalized children, 19,174 (36.3%) received antibiotics on the study day and 6,575 of these (12.5%) received broad-spectrum antibiotics. The overall prevalence of antibiotic use varied across hospitals from 22.3% to 51.9%. Antibiotic use prevalence was 29.2% among medical patients and 47.7% among surgical patients. Although there was no significant seasonal variation in antibiotic use prevalence, regional prevalence varied, ranging from 32.7% in the Midwest to 40.2% in the West (P < .001). Among units, pediatric intensive care unit patients had the highest prevalence of both overall and broad-spectrum antibiotic use at 58.3% and 26.6%, respectively (P < .001).
CONCLUSIONS: On any given day in a national network of children's hospitals, more than one-third of hospitalized children received an antibiotic, and 1 in 8 received a broad-spectrum antibiotic. Variation across hospitals, setting and regions identifies potential opportunities for enhanced antibiotic stewardship activities.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32141424     DOI: 10.1017/ice.2019.373

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  4 in total

1.  A Multicenter Analysis of Changes in Pediatric Antibiotic Susceptibilities Among Staphylococcus aureus and Pseudomonas aeruginosa Isolates: 2014-2018.

Authors:  Jeremy S Stultz; Emily Benefield; Kelley R Lee; Ferras Bashqoy; Amy L Pakyz
Journal:  J Pediatr Pharmacol Ther       Date:  2022-05-09

2.  Variability in Ceftriaxone Dosing Across 32 US Acute Care Children's Hospitals.

Authors:  Rina A Ferguson; Joshua C Herigon; Brian R Lee; Mari M Nakamura; Jason G Newland
Journal:  J Pediatric Infect Dis Soc       Date:  2021-05-28       Impact factor: 3.164

3.  Antibiotic-Associated Adverse Events in Hospitalized Children.

Authors:  Rebecca G Same; Alice J Hsu; Sara E Cosgrove; Eili Y Klein; Joe Amoah; Adam L Hersh; Matthew P Kronman; Pranita D Tamma
Journal:  J Pediatric Infect Dis Soc       Date:  2021-05-28       Impact factor: 3.164

4.  Assessment of Temporal Patterns and Patient Factors Associated With Oseltamivir Administration in Children Hospitalized With Influenza, 2007-2020.

Authors:  Patrick S Walsh; David Schnadower; Yin Zhang; Sriram Ramgopal; Samir S Shah; Paria M Wilson
Journal:  JAMA Netw Open       Date:  2022-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.